Late survival after abdominal aortic repair: Influence of coronary artery

Size: px
Start display at page:

Download "Late survival after abdominal aortic repair: Influence of coronary artery"

Transcription

1 Late survival after abdominal aortic repair: Influence of coronary artery aneurysm disease L. H. HoNer, M.D., G. Plate, M.D., P. C. O'Brien, Ph.D., F. J. Kazmier, M.D., P. Gloviczki, M.D., P. C. Pairolero, M.D., and K. J. Cherry, M.D., Rochester, Minn. To evaluate long-term survival in relation to preoperative risk factors, we reviewed 1112 patients undergoing abdominal aortic aneurysm (AAA) repair from 1970 to A 6-to 12-year follow-up was obtained on 1087 patients (97.7%) by chart review, death certificates, autopsy reports, and questionnaires returned by patients and referring physicians. Preoperatively 24% of patients had a history of prior myocardial infarction, 19.9% had a history of angina, and 40.4% were hypertensive. Emergency operation for ruptured aneurysm was performed in 6.5% and for expanding aneurysm in 3.4% of patients. The survival rate at 5 years was 67.5% and at 10 years was 40.7%. Cardiac-related problems were the most frequent cause of death (38%); 23% died of myocardial infarction and 15% from other heart disease or sudden death. Other causes included neoplasm (14.6%), other ruptured aneurysm (8.2%), and stroke (6.8%). Cause of death was unknown in 19.6%. A significant correlation of reduced survival time was noted in patients with advanced age and those with evidence of heart disease or hypertension. For patients without preoperative evidence of heart disease or hypertension, the 5-year mortality rate from myocardial infarction was 3.7%, compared with 11.7% for those with a positive history of hypertension and heart disease (p = ). For patients with no preoperative evidence of hypertension or heart disease, the length of survival after AAA repair was the same as that expected for the general population with the same age and sex composition. This study supports the contention that coronary angiography and prophylactic coronary bypass grafting should be performed selectively. Decisions regarding the need for coronary revascularization should be based on symptoms, noninvasive testing, and selective coronary angiography because aneurysmal disease alone is not shown in this study to increase the risk of death from myocardial disease. For patients with clinical findings of coronary artery disease, an aggressive diagnostic approach appears to be justified. (J VAse SURG 1984; 1:290-9.) Abdominal aortic aneurysm (AAA), unlike other atherosclerotic-related diseases, has shown a steady increase over the past 30 years and currently affects over 6% of the U.S. population over the age of65. I In 1950 Estes 2 showed that patients with an infrarenal AAA had a markedly shortened life expectancy compared with the population at large. DeBakey et al? in 1964 and Szilagyi et al. 4 in 1966 clearly demonstrated that patients undergoing aneurysm repair survived longer than patients whose aneurysms were managed nonoperatively. However, it was also noted that the survival time of these surgical patients was still less than that of the general From the Department of Surgery, the Department of Medical Statistics and Epidemiology, and the Department of Internal Medicine, Mayo Clinic. Presented at the Thirty-seventh Annual Meeting of the Society for Vascular Surgery, San Francisco, Calif., June 17-18, Reprint requests: L. H. Hollier, M.D., Department of Surgery, Mayo Clinic, Rochester, MN population. It has been subsequently shown by many authors ~ 14 that coronary artery disease was the major cause of death in these patients. Stimulated by findings of a high incidence coronary occlusive lesions in patients with AAA, 1~ surgeons in several centers performed prophylactic coronary artery revascularization in the hope of decreasing operative mortality rates and improving length of survival. 1 ''2,~G Patients undergoing AAA repair after successful coronary artery bypass grafting clearly have a lower operative mortality rate than those without coronary artery bypass grafting in some institutions, 12 but these patients represented a cohort who often had less severe coronary artery disease and who had survived coronary artery bypass surgery. Approximately 10% of those patients with AAA were believed to have nonreconstructible coronary artery disease and received neither coronary artery revascularization nor AAA repair. 12 In 1980 Brown et al? showed that elective AAA repair 290

2 Volume 1 Number 2 March 1984 Abdominal aortic aneurysm repair 291 Table I. Cause of late death after successful AAA repair Cause No. % of deaths Myocardial infarction Cardiovascular collapse Stroke Other ruptured aneurysm Neoplasia Pulmonary embolism Pneumonia Other known causes Unknown could result in a low mortality rate without routine coronary angiography or prophylactic coronary artery bypass grafting. Routine coronary revascularization appeared to be unjustified except in patients "~:ith symptomatic coronary artery disease. It remained our belief that noninvasive clinical criteria were adequate to detect those patients at greatest risk of myocardial infarction during AAA repair; our operative mortality rate from myocardial infarction for these patients without a history of coronary artery disease was 0.8%. ~ Hertzer, 17 in a 1983 review of over 1000 vascular patients undergoing routine coronary angiography, similarly concluded that most patients with significant coronary artery disease could be idcntificd by conventional clinical criteria. However, there remained the question of longterm survival. Does routinc coronary artery bypass grafting prolong life expectancy in patients with ancurysm? The answer to this question is not readily available, but the following points should be noted: (1) as mentioned previously, some patients with an- ~rysm have such diffuse coronary disease and poor ventricular function that myocardial revascularization is not feasible; (2) the mortality rate from atherosclerotic coronary artery disease in thc United States has been decreasing ovcr the past 10 years independent of any surgical influence18; and (3) although coronary artery bypass grafting appears to have improved the survival time of patients with left-main and three-vessel coronary artery disease, the CASS study, '9 thc European coronary artcry study, 2 and the Duke study 2~ have not yet shown an improved survival time for patients with less extensive asymptomatic coronary artery disease. In view of this information, recent rcports of improved survival time after prophylactic coronary artery bypass grafting and AAA repair cannot be compared with nonconcomitant reports on survival time after AAA Table II. Differences among long-term survival curves of several risk factor categories (death from all causes) Risk factor Age <0.001 Heart disease <0.001 Hypertension Angina pectoris Previous myocardial infarction Surgical indication Year of surgery 0.3 Coronary bypass 0.3 Renal revascularization 0.4 Tobacco use 0.4 repair alone. Two studies done at different times may not be truly comparable, and hence reasonable validity may not be guaranteed. We all agree that significant symptomatic coronary artery disease requires further evaluation and possibly coronary artery bypass grafting prior to elective AAA repair. However, would we improve the survival time of patients with AAA if they all underwent routine prophylactic coronary artery bypass grafting? In other words, in a patient with no clinical history of coronary artery disease, does the mere presence of an AAA indicate a greater risk of death from heart disease than exists in the population at large? In addition, can one identify a subset ofaneurysm patients who are at greater risk of death from myocardial infarction and in whom coronary angiography and myocardial revascularization could be expected to prolong life? METHOD OF STUDY In an attempt to answer some of these questions, we performed a retrospective analysis of clinical findings, operative mortality rates, and length of survival of all 1112 patients undergoing AAA repair at Mayo Clinic over the 6-year period from January 1, 1970, to December 31, Information was obtained by chart review of all patients and by questionnaires and/or telephone interviews with the patient or patient's family and with the referring physician. Death certificates were obtained for patients who died, and autopsy reports were obtained for all patients who underwent postmortem examination. Complete follow-up of 6 to 12 years was available for 1087 patients, or 97.7%. Variablcs reviewed included sex, year of surgery, indication for surgery (elective, urgent, or rupture), preoperative risk factors, operative death, long-term survival, and cause p

3 292 Hollier et al. Journal of VASCULAR SURGERY Table III. Differences among long-term survival curves of several risk factor categories death from all causes, death from MI or CV collapse, and death from MI only) Risk factor All causes MI / CV collapse MI only Age < Hypertension >0.20 Angina pectoris <0.001 <0.001 Previous MI <0.001 <0.001 Angina or prior MI <0.001 <0.001 Other cardiac abnormality < <0.001 (CHF, arrhythmia) Any heart disease <0.001 <0.001 <0.001 MI myocardial infarction; CV = cardiovascular; CHF = congestive heart failure. of death. Particular attention was given to preoperative findings of hypertension, angina, and prior myocardial infarction. Excluded were all patients who had had previous surgery for AAA. Detailed long-term survival curves and frequency distributions for multiple variables were computer generated. Table I provides the distribution of causes of late death for the 621 patients (58.3%) known to have died up to 2 years after successful aneurysm repair. Separate analyses are provided for death from all causes, death from myocardial infarction only (with other deaths considered as censored observation), and death from any cardiac-related cause. Deaths from these variables are analyzed additionally in relation to isolated and multiple preoperative risk factors, such as the year of surgery, tobacco use, concomitant renal revascularization, age, angina, prior myocardial infarction, and hypertension (Table II). The relationship between specific risk factors and survival time is investigated in several manners. Risk factors are individually and jointly analyzed as they relate to overall survival time and to death from all causes, death from myocardial infarction only, and death from any cardiac-related event (Table III). Survival curves were obtained by the Kaplan-Meier method 22 for each subgroup of patients, with comparison among subgroups based on likelihood ratio tests with the Cox model. 8 Association between continuous variables (such as age) and survival time was based on either the Cox regression model or a logic-rank procedure. 23 Comparisons with expected survival time were based on Hyde's procedure. 21 PATIENT INFORMATION Computer analysis provided frequency distributions for each of the variables in the study. Of the patients undergoing aneurysm repair, 974 (87.6%) were men. Age at operation ranged from 31 to 87 years in men and from 27 to 91 years in women (overall median age 68 years). ;~ Tobacco use was prevalent in 81.3% of patients, and 40.4% were hypertensive. Preoperative cardiac disease was identified clinically in 51.4% of the patients, with 19.9% having angina, 24.0% having a prior history of myocardial infarction, and 26.1% having some other manifestation of cardiac dysfunction, for example, arrhythmia, abnormal ECG, or congestive heart failure. Two hundred thirty patients (20.7%) had hypertension and no cfinical evidence of coronary disease, and 342 patients (30,7%) had coronary artery disease with no hypertension. Two hundred seventeen patients (19.5%) had both hypertension and coronary artery disease. Two hundred ninety-eight patients (26.8%) had neither hypertension nor heart disease at the time of aneurysm repair. The operations performed in each of the 6 years were roughly equal in number. Thirty-four patien,~ (3.1%) had concomitant renal artery surgery, and eight of these had bilateral renal artery revascularization. Coronary artery bypass had been performed on only 17 patients (1.5%) prior to AAA repair. Only 20 patients (1.8%) had coronary artery bypass grafting after AAA repair. All coronary artery bypasses were done for severely symptomatic coronary artery disease. Elective aneurysm resections were performed for 998 patients (90.1%), whereas 38 patients (3.4%) had surgery after a diagnosis of acutely expanding aneurysm and 72 patients (6.5%) after rupture of the aneurysm. GENERAL SURVIVAL TIME One thousand sixty-six patients survived surgical repair of the AAA, an overall 30-day operative mortality rate of 4.1%. Surgery for ruptured AAA car-

4 Volume 1 Number 2 March 1984 Abdominal aortic aneurysm repair 293 loo (96.11 ~.~. Over All 6o. ~''''~-~ (79.6) (90.9) ~ "''''~.~ (58.01 ~ 60 i (67.5) ~.... 4O Expected 20 ~ Observed (n : P < o (40.7) Years Fig. 1. Survival curves depicting a comparison between observed survival time, from AAA repair to death from all causes, and expected survival time of the age- and sexmatched general population. loo 8o ~ 60 } 'e. ~ 4o 2O Expected "',.. p ~ Nonruptured {n=1009) "... ~.... Ruptured (n=53) "'-.. I 2 I, I 6 I s,o ' 1'2 I I I Years Fig. 2. Survival time of patients undergoing elective aneurysm repair compared with that of patients undergoing repair of ruptured aneurysms. Operative death is excluded; death from all other causes is included. ried a 26.4% mortality rate, whereas the mortality race for both urgent and elective resection was 2.6% in each case. When deaths from all causes are considered, the probability of surviving 1, 5, and 10 years after successftd surgery is 90.9%, 67.5%, and 40.7%, respectively. These statistics assume that survival distribution in patients lost to follow-up or in those who have had a more recent operation will be the same as in those whose information is available. Median survival time is about 7.25 years. In addition to describing survival time, an expected survival curve was completed to compare survival time preceding all causes of death in this group with survival time in an age- and sex-matched cohort based on west-north central United States life tables. Survival at 5 years is about 84.8% of that expected, and at 10 years observed survival is about 70.2% of that expected (Fig. 1). Available expected ~vival curves are not appropriate for comparison with the disease-specific survival rates. RELATIONSHIPS OF RISK FACTORS TO SURVIVAL TIME Among the risk factors investigated, all but sex, year of surgery, use of tobacco, and renal revascularization appear to influence survival time (Table *II). All the variables measuring preoperative cardiovascular problems were found to decrease survival time significantly. Even excluding hospital deaths, significantly longer survival time was found among patients undergoing elective aneurysm repair than among those undergoing urgent repair or repair of ruptured aneurysms (p = 0.046) (Fig. 2). As expected, survival for all patients is strongly related to the age of the patient (p < 0.001) (Fig. 3, A and B). When deaths from myocardial infarction only are examined, however, there is no statistically significant association with age (p > 0.1). Within each age group, patients with heart disease had shorter survival times than did those without heart disease. This difference was significant in both groups when deaths from all causes and those from myocardial infarction were analyzed. Preoperative hypertension is associated with decreased survival time (p < 0.001) when all deaths are analyzed, but preoperative hypertension appears to have no influence on death from myocardial infarction only (p > 0.1). The overall survival time appears slightly better for those patients with hypertension only than for those with heart problems only, but the difference is not statistically significant (Fig. 4). Patients with a preoperative myocardial infarction, preoperative angina, or both appear to have a shorter survival time than those without either condition (none to either p = 0.012; none to both p = 0.005) (Fig. 5). The amount of time between a preoperative myocardial infarction and operation has been noted to affect hospital mortality rates 24 but did not affect long-term survival (p > 0.1). Seventeen patients had preoperative coronary artery bypass grafting. No statistically significant association was observed between prior coronary bypass and long-term survival (p > 0.2), but the reason may be the small sample size. Patients with both preoperative heart disease and hypertension have significantly shorter survival times than those with either condition alone (p < 0.005) or with neither condition (p < 0.001) (Fig. 6, A). For patients without preoperative evidence of heart disease or hypertension, the 5-year mortality rate from documented myocardial infarction was 3.7%, compared with 11.7% for those with a positive his-

5 294 Hollier et al. Journal of VASCULAR SURGERY 100~.~..,7) (92 8) Age < 60 Years Exp~ted p 0,001 (~) o,oo ~.(97.1) " ~'''-... "''''-.. (84.3) Age 6g-6g Years ~ Age > 70 Years. (72.5) ~.~"- ao """ -'''"--.. (s5.5),oo,(o3.g)... -~ (6g2) ~ ~40 ~ (4s.5) ~ ~,o ~ Ob.rv*d(n:471) ~n-420) ~);pecte~ (420)... p<o.o0~ (28.5) (2g.5)~'~ Years Years Fig. 3. Three survival curves demonstrating influence of age on long-term survival after AAA repair compared with survival of the age- and sex-matched general population (death from all causes was included). Note relative lessening of survival difference in patients over the age of 70 years ~ so ~,o Expected - - Hypertension alone (n=216)... Heart disease alone (n=334) I I I I [ '2 Years Fig. 4. Influence of hypertension alone and heart disease alone on long-term survival, from successful aneurysm repair to death from all causes. tory (p = 0.001). This same result was observed for all cardiac-related deaths (p < 0.001) with 5-year survival rates of 77.3% and 66.8%, respectively. Perhaps most importantly, however, in those patients who had no hypertension and no clinical evidence of heart disease prior to AAA repair, the overall long-term survival remained essentially no different (p > 0.4) from that of the age-matched population at large (Fig. 6, B). DISCUSSION Retrospective analysis of data is fraught with many potential deficiencies. Of particular concern in survival studies is the reliability of determining factual cause of death. For verification of medical information in this study, autopsy reports and death certificates were obtained and clarification of any ambiguity was sought from the attending physician and family. Although errors in diagnosis of death may occur, they have been minimized as much as possible. The age and sex distribution is comparable to other, similar reports in the literature, 1)'13"14 an~ these patients reflected a similar incidence and d~tribution of risk factors. As in other studies,* coronary artery disease continues to be a major factor in postoperative death and long-term survival, but subgroups with greater and lesser risks can be developed. In addition, noncardiac risk factors have varying importance in long-term survival. Somewhat surprisingly, smoking did not appear to adversely influence late mortality rates in this series. A similar lack of adverse effect of smoking on the incidence of angina pectoris and the risk of myocardial infarction has also been reported from the Framingham study for persons over 50 years of age. z~ As one might expect, actual survival time after aneurysm repair is very strongly related to the age of, the patient. However, if one evaluates length of *References 3-5, 11-14, 16.

6 Volume 1 Number 2 March 1984 Abdominal aor-tic aneurysm repair 295 Previous Myocardial Infarction Hypertension and Heart Disease Expected -0bser ed (n=20,, (20.5) Angina PeCtOriS Expected -NO angina, =*a,.. ( S 207, P = ; I a L ; k Ib L, * Year5 Fig. 5. Influence of previous myocardial infarction, A, and angina pectoris, B, on long-term survival, from successful AAA repair to death from all causes. survival in relation to expected survival time for specific age groups, the difference appears to diminish with advancing age (69% of expected for patients less than 60 years of age compared with 72% of expected for those older than 70 years of age), although it is not statistically significant. Of particular interest is the finding that 11.8% of patients who survived AAA repair subsequently died of rupture of another aneurysm or a late complicaan of the original aneurysm repair. Crawford and Cohen9 previously noted the prevalence of additional aneurysms in other segments of the aorta and the high incidence of late development of other aneurysms. These factors suggest that patients who undergo aneurysm repair should be followed up closely for the development of other aneurysms over the ensuing years. Although B-mode ultrasound scanning is a useful screening tool for AAAs, it is somewhat less effective in delineating thoracic, suprarenal, and iliac aneurysms unless special studies are performed. We have found computerized tomography to be much more definitive for these particular areas and would suggest that it be used for complete aortic evaluation. Hypertension significantly reduced survival time but had no influence on death from myocardial infarction alone. Death from stroke, however, was Fig. 6. A, Influence of combined hypertension and heart disease on long-term survival, from successful AAA repair to death from all causes. B, Long-term survival of patients who have no hypertension and no overt heart disease following successful AAA repair. This is the same as the expected survival time of an age- and sex-matched general population. more commonly associated with patients having hypertension, as was death from rupture of other aneurysms. In addition, hypertension further decreased survival time in those patients who also had clinical evidence of coronary artery disease (p < 0.005). DeBakey et a1.3 in 1964 similarly noted the differential risks in patients with hypertension and heart disease. It appears, therefore, that strict control of hypertension could potentially improve long-term survival rates by decreasing mortality rates associated with myocardial infarction, stroke, and aneurysmal rupture. Obviously, there is a need for further clarification of the interrelationship of hypertension with other risk factors in patients with AAA. Only 17 of the 1112 patients in this study had undergone prior coronary bypass. After repair of the aneurysm, at least 181 patients (16.3%) had a nonfatal myocardial infarction sometime after surgery, and at least 254 patients (22.8%) had angina in the late postoperative period. Nevertheless, only 20 of these patients having aneurysm repair between 1970 and 1976 underwent subsequent myocardial revas-

7 296 Hollier et al. Journal of VASCULAR SURGERY cularization. Although one would expect that patients who had coronary revascularization would have a prolonged survival time, such was not the case. There may be several explanations. One possible explanation is that other previous reports showing increased survival time after myocardial revascularization used nonconcurrent controls for comparison. ~,'2"~,~ Because there has been a general reduction in cardiovascular-related deaths in this country over the past 10 to 12 years, ~s the improved survival time of coronary bypass patients may merely reflect recent general trends in the population. Because our study reports time-matched controls, this false improvement in survival time would not be present. The most likely explanation, however, is the very small number of patients in our study who underwent coronary artery bypass grafting. It appears likely that we had an insufficient data base for valid comparison and thus could not demonstrate the improvement in long-term survival in the coronary bypass patient. Both the CASS study TM and the European coronary artery study 2 clearly demonstrate the superiority of coronary bypass over medical treatment for symptomatic coronary artery stenosis. AAAs continue to represent significant morbidity and mortality rates in our elderly population. Although aneurysm repair clearly prolongs life, the long-term survival of these patients following successful surgery remains less than the survival time of the population at large, with the 10-year survival rate being only 70% of the expected rate. Our study, as well as others, '~'~-~4 has documented coronary artery disease as the major cause of death in these patients. It has been suggested that coronary revascularization may improve both the operative and long-term survival of these patients. We have previously demonstrated that aneurysm repair can be accomplished safely without prophylactic coronary revascularization 5 and that delaying aneurysm repair appears to result in an increase in aneurysm rupture. Crawford et al. ~ have noted that "a significant number of patients ruptured their aneurysm while recovering from their bypass operation"; these authors further suggested performing prophylactic coronary bypass surgery only in patients with impending infarction and treating the other patients medically until a later date, after recovery from aneurysm operation. ~' We have also used this approach. However, even after patients have recovered from aneurysm repair, we have generally reserved coronary revascularization for patients with limiting symptoms. In view of the markedly reduced survival time of patients with symptoms of coronary artcry disease, however, a more aggressive approach may be warranted. Despite the attractiveness of that line of reasoning, prophylactic coronary revascularization, even if limited only to patients with clinical evidence of coronary artery disease, has somc limitations. Because coronary artery bypass grafts do have a significant incidcnce of graft occlusion, v and reoperative coronary revascularization carries a somewhat higher mortality rate and reduced survival time, 26 routine coronary bypass of early asymptomatic lesions may put the patient at greater risk of myocardial infarction in the long run should graft failure occur. At present it appears that coronary artery bypass grafting for only mildly symptomatic onc- or two-vessel coronary artery disease (except left-mas.~ coronary artery disease) does not prolong life 6"~J~ and should not be undertaken for asymptomatic patients. A more effective approach might be to attempt to more clearly delineate those patients at greatest risk of death from myocardial infarction. Clearly, patients with no hypertension and no clinical evidence of heart disease have a normal life expectancy and are least likely to benefit from prophylactic coronary angiography and coronary bypass. On the other hand, patients with severe angina generally derive great benefit from myocardial revascularization. Those patients who have clinical evidence of stable coronary artery disease are more likely to demonstrate coronary stenosis on angiography, but not all would benefit from coronary bypass. 17 Further evaluation, however, is clearly indicated. Coronary angiography can identify and quantitare coronary artery stenosis, but the presence ofsteno}fs does not necessarily imply that myocardial infarction is likely, especially if extensive collaterals have developed. Stress ECGs seem to be insufficiently sensitive to identify all angiographic lesions, although the importance of those lesions might be questioned if they do not produce signs of ischemia with exercise. Multigated radionuclide scans appear to be useful in screening patients with coronary artery disease because they can provide quantitation of ventricular function and can identify wall motion abnormalities occurring with exercise. Left ventricular ejection fraction appears to correlate well with both operative mortality rates and long-term survival 6 and appears to have a high correlation to coronary lesions identified angiographically that pose significant risk of myocardial infarction. In fact, left ventricular function seems to be a more important

8 Volume 1 Number 2 March 1984 Abdominal aortic aneurysm repair 297 prediction of survival time than does the number of diseased vessels. ~ Perhaps the best method of evaluating stable patients for high risk of myocardial death is a combination of history and physical examination, ECG, multigated radionuclide scan of patients with findings suggestive of coronary artery disease, and coronary angiography limited to panents who have evidence of functional myocardial ischemia. An aggressive diagnostic approach certainly appears to be justified for patients who have clinical evidence of coronary artery disease. However, myocardial revascularization should perhaps be reserved for those patients with significant symptoms or life-threatening coronary lesions. REFERENCES "% BickerstaffLK. Hollier LH, Van Peenen HJ, Melton III LJ, Palrolero PC, Cherry KJ. Abdominal aortic aneurysms: The changing natural history. J VASC SURG 1984; 1: Estes Jr JE. Abdominal aortic aneurysm: A study of one hundred and two cases. Circulation 1950: 2: DeBakey ME, Crawford ES, Cooley DA. et al. Aneurysm of abdominal aorta: Analyses of results of graft replacement therapy one to eleven years after operation. Ann Surg 1964: 160: Szilagyi DE. Smith RE. DeRusso FJ, et al. Contribution of abdominal aort,c aneurysmectomy to prolongation of life. Ann Surg 1966: 164: Brown OW. Hotlier LH, Palrolero PC, et al. Abdominal aortic aneurysm and coronary artery disease: A reassessment. Arch Surg 1981: 116: Califf RM, Tomabechi Y, Lee KL, et al. Outcome in onevessel coronary artery disease. Circulation 1983; 67: Campeau L. Lesp4rance J, Hermann J, et al. Loss of the improvement of angina between one and seven years after aortocoronary bypass surgery. Circulation 1979: 60:I1-I5. 8. Cox DR. Regression models and life tables. JR Statistical Soc 1972: 34: *,... 9 Crawford ES, Cohen ES. Aortic aneurysm: A multi-focal disease. Arch Surg i982; 117: Crawford ES. Morris Jr GC, Howell JF, et al. Operative risk in patients with prev,ous coronary artery bypass. Ann Thorac Surg 1978; 26: Crawford ES, SalWa AS, Bagg III JW, et al. Infrarenal abdominal aortic aneurysm: Factors influencing survival after operation performed over a 25-year period, Ann Surg 1981; 193: , Hertzer NR. Fatal myocardial infarction following abdominal aortic aneurysm resection, Ann Surg 1980; 192: , Johnson Jr G, Gurri JA, Burnham SJ. Life expectancy after abdominal aortic aneurysm repair. In: Bergan JJ, Yao JST, eds. Aneurysms: Diagnosis and treatment. New York: Grune & Stratton, Inc, 1982: Thompson JE, Hollier LH, Patman RD, et al. Surgical management of abdominal aortic aneurysms: Factors influencing mortality and morbidity: A 20-year experience. Ann Surg 1975; 181: Hertzet NR, Young JR, Kramer JR, et al. Routine coronary angiography prior to elective aortic reconstruction. Arch Surg 1979; 114: McCollum CH, Garcia-Rinaldi R, Graham JM, et al. Myocardial revascularization prior to subsequent major surgery in patients with coronary artery disease. Surgery 1977; 81: FIertzer NR. Myocardial ischemia. Surgery 1983; 93: Fcinleib M, Havlik RJ, Thorn TJ. The changing pattern of ischemic heart disease. J Cardiovasc Med 1982; 7: Mock MB, Rengqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery (CASS) registry, Circulation 1982; 6& , European Coronary Artery Surgery Group. PrOspective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1980; 2: Hyde J. Testirlg survival under right censoring and left truncation. Biometrika 1977; Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53: O'Bricn PC. A non-parametric test for association with censored data. Biometrics 1978; 34: Tathan S, Moffitt EA, Taylor WF, et al. Myocardial infarction after general anesthesia. JAMA 1972; 220: Dawber TR. The Framingham study: The epidemiology of atherosclerotic disease. Cambridge, Mass: Harvard University Press, 1980: Loop FD, Cosgrove DM, Kramer JR, et al. Late clinical and arteriographic results in 500 coronary artery operations. J Thorac Cardiovasc Surg 1981; 81: DISCUSSION Dr. George Johnson, Jr. (Chapel Hill, N.C.). Dr. HolLier's data continue to add to the pool of developing knowledge on the longevity of patients on whom vascular surgeons operate. Last year Dr. Steven Burnham reported our late follow-up of patients operated on for AAA and for aortoiliac or femoropopliteal occlusive disease. The longevity following these operations was half that of the general population. The present report suggests that we might find a subset of these patients who are at a high risk for late death and in whom we could alter these risk factors. Stimulated by Dr, Hollier's abstract, we reviewed our experience. Five hundred fifty-six patients have had repair of their aortic aneurysm at North Carolina Memorial Hospital, and 453 of these survived the operation. The longevity of patients with risk factors, including hypertension, diabetes, heart disease, stroke, and azotemia, was compared with that of patients with none of these risk factors. The patients without any risk factors lived longer than those with risk factors, but not as long as the general population. We are surprised that Dr. Hollier was able to identify a group of these patients with manifest arteriosclerosis who lived as long as the control population. \

9 298 Hollier et al. Journal of VASCULAR SURGERY Perhaps we North Carolinians just do not live as long as the rest of you. One thing we did notice in the study (and it is a danger in all studies that look at the cause of late death) is the reliance on the death certificate. Many practicing physicians denote myocardial infarction as the cause of death when the true cause is unknown. For the absolute answer, we will have to await long-term results after coronary artery bypass grafting to sec whether this procedure will prolong survival. Another interesting point that we found in our series, and that Dr. Hollier emphasizes, is the longevity of the aged patient. The older the patient operated on in both series, the nearer the longevity approaches that of the general population. I am sure this is a reflection of patient selection. We agree that a reasonable attempt should be made to identify those patients with major risk factors and to correct the problems if possible before performing operations on patients with AAA. Dr. Norman R. Hertzer (Cleveland, Ohio). In an attempt to reduce the early and late mortality rates from myocardial infarction following peripheral vascular reconstruction, patients under consideration for vascular procedures at the Cleveland Clinic have been advised to undergo preoperative cardiac catherization since As we have emphasized on several occasions, the objective of our study of routine coronary angiography has always been to determine those patients for whom this approach would have the greatest benefit if used on a selective basis. Because our previous experience with survival time after aortic aneurysm resection is so similar to that described from the Mayo Clinic, you might be interested in a couple of results concerning the first 1000 patients included in our current investigation. A total of 302 of the 1000 patients had aortic aneurysms as a primary or incidental diagnosis. On the basis of the cardiac history and a standard ECG, coronary artery disease could be suspected in 158 patients even prior to cardiac catheterization. Severe, surgically correctable lesions were documented by angiography in 42% of this group, and severe, inoperable disease was identified in another 9.5%. No clinical evidence of coronary involvement was present in 144 of the 302 patients. Although surgically correctable coronary disease still was found in 19% and inoperable lesions were found in a few others, these differences were highly significant statistically. Significant differences in the incidence of severe coronary artery disease were also found in other subsets, most notably among men, patients over 60 years of age, and patients with diabetes. Nevertheless, previous symptoms or ECG indications of coronary disease--including ST-T segment changes, by the way--were critical features of correctable disease in all these groups. If patients with aneurysms have clinical evidence of coronary disease, angiography will demonstrate severe lesions in nearly 50%, most of which are amenable to myocardial revascularization. Use noninvasive screening if you will, but restrict it to those in whom coronary disease is not suspected on conventional grounds. Why be concerned about all this? For one thing, the operative mortality rate after aneurysm resection was only 1.6% among 61 patients in our current series who required preliminary myocardial revascularization because of survey coronary angiography. For another, 5-year actuarial survival after aneurysm resection at our center for patients with suspected but uncorrected coronary disease previously has been about 25% worse than for patients of the same age who receive coronary artery bypass. Most of this meaningful difference, of course, is caused by fatal myocardial infarction. We simply believe that many of these deaths can be prevented, and with a little patience, we hope to prove it. Dr. HoNer (closing). In response to Dr. Johnson's question concerning death certificates, we agree that those diagnoses are often in error. However, our study is not based solely on the cause of death, as you noted, but "~ based on death by any cause. Death is the one end poinf about which no statistician can argue. I appreciate your taking the time to again review your data. At this point I find it somewhat difficult to explain your failure to concur with our findings. I might point out that our findings are not entirely new. In i964 Dr. De- Bakey demonstrated that in patients who had no hypertension and no overt heart disease, long-term survival was markedly improved over that of patients who did have clinical hypertension, heart disease, or both. I urge Dr. Johnson to again examine his data and be sure that they are matched with a comparable age- and sex-matched cohort for comparison of the expected survival time. We all are indebted to Dr. Hertzer for the great contributions he has made in delineating the prevalence of coronary artery disease in vascular patients. His data demonstrate an improved operative mortality rate and an improved long-term survival rate in patients who have undergone successful coronary bypass and subsequently) have had aneurysm repair in recent years. However, one must be cautious when comparing current surgical patients with patients who had surgery 15 years ago. Over the past 10 years there has been an overall reduction in death from coronary artery disease in this country, and this reduction appears to be independent of the advent of coronary bypass. In addition, bias in selection occurs against patients who undergo aneurysm repair, since 4% to 10% of aneurysm patients have such severe coronary artery disease that coronary bypass is not undertaken. Although coronary angiography can identify and quantitate coronary stenosis, the presence ofstenosis does not necessarily imply that myocardial infarction is likely. In fact, left ventricular function may perhaps be a more important predictor of survival than is the number of diseased vessels. Further, let us not forget that age is one of the major predictors of the operative mortality rate, particularly for coronary bypass. Multiple reports on the

10 Volume 1 Number 2 March 1984 Abdominal aortic aneurysm repair 299 CASS study clearly demonstrate that the mortality rate for myocardial revascularization is increased after the age of 65 years. In patients over the age of 65 to 70 years, perhaps the issue is not so much prophylactic coronary surgery for survival but the role of this surgery in improving the quality of life for symptomatic patients who have clinical evidence of coronary artery disease and for whom an aggressive diagnostic approach certainly is justified. However, myocardial revascularization of patients in this age group should perhaps be reserved for those with significant symptoms or maly life-threatening lesions.

Resection of abdominal aortic aneurysm patients with low ejection fractions

Resection of abdominal aortic aneurysm patients with low ejection fractions Resection of abdominal aortic aneurysm patients with low ejection fractions in Richard L. McCann, MD, and Walter G. Wolfe, MD, Durham, N.C. The perioperative and long-term survival of patients who undergo

More information

Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses

Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses R. James Valentine, MD, John D. Martin, MD, Smart I. Myers, MD, Matthew

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Preoperative Management. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee

Preoperative Management. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Preoperative Management Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Perioperative Care Consideration Medical care provided to prepare

More information

Surgery for patients with diffuse atherosclerotic disease

Surgery for patients with diffuse atherosclerotic disease Surgery for patients with diffuse atherosclerotic disease Special hospital for surgery Skopje Macedonia September, 2012 Mitrev Z, Anguseva T, E.Stoicovski, Hristov N, E.Idoski Oktomvri, 2008 Atherosclerosis

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

Coronary atherosclerotic heart disease remains the number

Coronary atherosclerotic heart disease remains the number Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,

More information

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis W. C. Alford, Jr., M.D., I. J. Shaker, M.D., C. S. Thomas, Jr., M.D., W. S. Stoney, M.D., G. R. Burrus, M.D., and H. L. Page,

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Abdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke

Abdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized

More information

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit 98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper

More information

Operative Risk in Patients with Previous Coronary Artery Bypass

Operative Risk in Patients with Previous Coronary Artery Bypass Operative Risk in Patients with Previous Coronary Artery Bypass E. Stanley Crawford, M.D., George C. Morris, Jr., M.D., Jimmy F. Howell, M.D., William F. Flynn, M.D., and Dudley T. Moorhead, M.D. ABSTRACT

More information

Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair

Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair 583 Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair Frank R. Arko, MD; W. Anthony Lee, MD; Bradley B. Hill, MD; Paul Cipriano,

More information

CONDITIONAL REGRESSION MODELS TRANSIENT STATE SURVIVAL ANALYSIS

CONDITIONAL REGRESSION MODELS TRANSIENT STATE SURVIVAL ANALYSIS CONDITIONAL REGRESSION MODELS FOR TRANSIENT STATE SURVIVAL ANALYSIS Robert D. Abbott Field Studies Branch National Heart, Lung and Blood Institute National Institutes of Health Raymond J. Carroll Department

More information

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2008 Update Plus Overview of the Guidelines Concept John Coyle, M.D. October 16, 2008 The History of Medicine As Mountaineering Feat

More information

Experience of endovascular procedures on abdominal and thoracic aorta in CA region

Experience of endovascular procedures on abdominal and thoracic aorta in CA region Experience of endovascular procedures on abdominal and thoracic aorta in CA region May 14-15, 2015, Dubai Dr. Viktor Zemlyanskiy National Research Center of Emergency Care Astana, Kazakhstan Region Characteristics

More information

Management of the persistent sciatic artery with coexistent aortoiliac aneurysms; endovascular and open techniques.

Management of the persistent sciatic artery with coexistent aortoiliac aneurysms; endovascular and open techniques. ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 14 Number 2 Management of the persistent sciatic artery with coexistent aortoiliac aneurysms; endovascular and open A Rodriguez-Rivera,

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

The American Experience

The American Experience The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

More information

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090)

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090) Local Coverage Determination (LCD) for Cardiac Catheterization (L29090) Contractor Information Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B LCD

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD

More information

and Paul C. Taylor, M.D. ORIGINAL ARTICLES

and Paul C. Taylor, M.D. ORIGINAL ARTICLES ORIGINAL ARTICLES Trends in Selection and Results of Coronary Artery Reoperations Floyd D. Loop, M.D., Bruce W. Lytle, M.D., Carl C. Gill, M.D., Leonard A. R. Golding, M.D., Delos M. Cosgrove, M.D., and

More information

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir

More information

Renal insufficiency after infrarenal abdominal aortic aneurysm reconstruction: An analysis of this risk factor in 45 patients

Renal insufficiency after infrarenal abdominal aortic aneurysm reconstruction: An analysis of this risk factor in 45 patients Original Research Medical Journal of the Islamic Republic of Iran.Vol. 21, No.1, May, 2007. pp. 38-42 Renal insufficiency after infrarenal abdominal aortic aneurysm reconstruction: An analysis of this

More information

Combined coronary artery bypass grafting and bilateral renal revascularization for unstable angina and impending renal failure

Combined coronary artery bypass grafting and bilateral renal revascularization for unstable angina and impending renal failure Combined coronary artery bypass grafting and bilateral renal revascularization for unstable angina and impending renal failure Robert A. McCready, MD,* Harry Siderys, MD, ~ Peter R. Foster, MD,*~ and Bruce

More information

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient

More information

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization Richard D. Schultz, M.D., Antonio V. Sterpetti, M.D., and Richard J. Feldhaus, M.D. ABSTRACT A ten-year review

More information

AAA CAG CAG. ACC / AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac. Group Group AAA AAA.

AAA CAG CAG. ACC / AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac. Group Group AAA AAA. 13 591 596 2004 AAA CAG CAG 5527 15 CAG ACC / AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery CAG 55 34 62CAG 75 CAG 73 63 66 ACC / AHA CAGGroup 1 9 8 Group 225 22 Group

More information

Research Article Survival Comparison of Patients Undergoing Secondary Aortic Repair

Research Article Survival Comparison of Patients Undergoing Secondary Aortic Repair Advances in Vascular Medicine Volume 2015, Article ID 395921, 5 pages http://dx.doi.org/10.1155/2015/395921 Research Article Survival Comparison of Patients Undergoing Secondary Aortic Repair Dean J. Yamaguchi,

More information

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Yearly Rupture or Dissection Rates for Thoracic Aortic Aneurysms: Simple Prediction Based on Size

Yearly Rupture or Dissection Rates for Thoracic Aortic Aneurysms: Simple Prediction Based on Size ORIGINAL ARTICLES: CARDIOVASCULAR Yearly Rupture or Dissection Rates for Thoracic Aortic Aneurysms: Simple Prediction Based on Size Ryan R. Davies, BA, Lee J. Goldstein, MD, Michael A. Coady, MD, Shawn

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE

THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

Supplementary Online Content

Supplementary Online Content 1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing

More information

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Peri-operative Troponin Measurements - Pathophysiology and Prognosis Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Abdominal and thoracic aneurysm repair

Abdominal and thoracic aneurysm repair Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts

More information

Annals of Internal Medicine

Annals of Internal Medicine 15 January 1993 Volume 118 Number 2 Annals of Internal Medicine Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease David B. Pryor, MD; Linda Shaw, AB;

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

More information

Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the

Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the Title page Manuscript type: Meta-analysis. Title: Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long- term effects of screening for abdominal

More information

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,

More information

Epidemiology of Aortic Aneurysm Repair in the United States from 1993 to 2003

Epidemiology of Aortic Aneurysm Repair in the United States from 1993 to 2003 Epidemiology of Aortic Aneurysm Repair in the United States from 1993 to 2003 JOHN A. COWAN, JR., JUSTIN B. DIMICK, PETER K. HENKE, JOHN RECTENWALD, JAMES C. STANLEY, AND GILBERT R. UPCHURCH, Jr. University

More information

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees

More information

Accepted Manuscript. Perioperative renal function and thoracoabdominal aneurysm repair: Where do we go from here? Leonard N. Girardi, M.D.

Accepted Manuscript. Perioperative renal function and thoracoabdominal aneurysm repair: Where do we go from here? Leonard N. Girardi, M.D. Accepted Manuscript Perioperative renal function and thoracoabdominal aneurysm repair: Where do we go from here? Leonard N. Girardi, M.D. PII: S0022-5223(18)31804-X DOI: 10.1016/j.jtcvs.2018.06.057 Reference:

More information

Open Vascular Surgery

Open Vascular Surgery Open Vascular Surgery Still Relevant in 2017? Carotid Endarterectomy vs Stenting? Aortic Endografts vs Grafting? Mesenteric Stents vs Reconstruction? Saphenous Stripping vs RFA? Carotid Endarterectomy

More information

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis.

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction Talley J D, Ohman E M, Mark D B, George B S, Leimberger J D, Berdan L

More information

Registry of Endovascular Aneurysm Registry data report

Registry of Endovascular Aneurysm Registry data report SPECIAL REPORT Lifeline Repair: Registry of Endovascular Aneurysm Registry data report Lifeline Registry of Endovascular Aneurysm Repair Steering Committee Purpose: The goal of the Lifeline Endovascular

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Coronary artery bypass grafting (CABG) is a temporary treatment for a Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular

More information

Death and adverse cardiac events after carotid endarterectomy

Death and adverse cardiac events after carotid endarterectomy Death and adverse cardiac events after carotid endarterectomy David J. Musser, MD, Gary G. Nicholas, MD, and James F. Reed III, PhD, Allentown, Pa. Purpose: This study evaluated operative mortality rate

More information

PCI for Renal Artery stenosis

PCI for Renal Artery stenosis PCI for Renal Artery stenosis Why should we treat Renal Artery Stenosis? Natural History of RAS RAS is progressive disease Study Follow-up (months) Pts Progression N (%) Total occlusion Wollenweber Meaney

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

June 25, RE: CMS-1588-P - Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment System and Fiscal Year 2013 Rates

June 25, RE: CMS-1588-P - Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment System and Fiscal Year 2013 Rates June 25, 2012 Ms. Marilyn Tavenner Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1588-P P.O. Box 8011 Baltimore, MD 21244-8050 RE:

More information

Setting The setting was a hospital. The economic study was carried out in Australia.

Setting The setting was a hospital. The economic study was carried out in Australia. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,

More information

Abdominal Aortic Aneurysms

Abdominal Aortic Aneurysms Abdominal Aortic Aneurysms A Reappraisal By IRWIN J. SCHATZ, M.D., JOHN F. FAIRBAIRN II, M.D., AND JOHN L. JUERGENS, M.D. PRIOR to the advent of successful reconstructive aortic surgery, abdominal aortic

More information

Clinical Policy Title: Abdominal aortic aneurysm screening

Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next

More information

The Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA)

The Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA) The Management and Treatment of Ruptured Abdominal Aortic Aneurysm (RAAA) Disclosure Speaker name: Ren Wei, Li Zhui, Li Fenghe, Zhao Yu Department of Vascular Surgery, The First Affiliated Hospital of

More information

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands

More information

ery: Comparison of Predicted and Observed Resu ts

ery: Comparison of Predicted and Observed Resu ts Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

Supplement Table 1. Definitions for Causes of Death

Supplement Table 1. Definitions for Causes of Death Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death

More information

Renal Artery Stenosis: Insights from the CORAL Trial

Renal Artery Stenosis: Insights from the CORAL Trial Renal Artery Stenosis: Insights from the CORAL Trial Christopher J. Cooper, M.D., FACC, FACP Dean and Senior Vice President University of Toledo, College of Medicine President, Ohio Chapter ACC State of

More information

ChoMithiasis and aortic reconstruction

ChoMithiasis and aortic reconstruction ChoMithiasis and aortic reconstruction S. Timothy String, M.D., Mobile, Ala. Identification of cholelithiasis during abdominal aortic reconstruction with placement of a vascular prosthesis provides cause

More information

EndoVascular Aneurysm Sealing (EVAS) with Nellix

EndoVascular Aneurysm Sealing (EVAS) with Nellix 1 2 EndoVascular Aneurysm Sealing (EVAS) with Nellix Designed to seal entire aneurysm with contained biostable polymer Non-modular design with complete fixation Expands endovascular patient eligibility

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX

FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX 2018 A BIT OF HISTORY First use of F-EVAR : 1990s Park et al. J Vasc Interv Radiol. 1996;7:819-823. Faruqi et al. J Endovasc Surg.

More information

DIAGNOSTIC CRITERIA OF AMI/ACS

DIAGNOSTIC CRITERIA OF AMI/ACS DIAGNOSTIC CRITERIA OF AMI/ACS Diagnostic criteria are used to validate clinical diagnoses. Those used in epidemiological studies are here below reported. 1. MONICA - Monitoring trends and determinants

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

Recording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester

Recording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester Recording and Evaluation of Co-Morbidity - An Update Jill Birch University of Manchester Introduction Co-morbidity included in Adult cancer datasets from outset Measures to be used uncertain Uncertainty

More information

Operative Mortality and Long-term Relative Survival of Patients Operated on for Asymptomatic Abdominal Aortic Aneurysm

Operative Mortality and Long-term Relative Survival of Patients Operated on for Asymptomatic Abdominal Aortic Aneurysm Eur J Vasc Endovasc Surg 9, 293-298 (1995) Operative Mortality and Long-term Relative of Patients Operated on for Asymptomatic Abdominal Aortic Aneurysm Steinar Aune, Svein R. Amundsen, Jens Evjensvold

More information